ResMed Inc (RMD)

173.88 -2.12  -1.20% NYSE Feb 21, 20:00 Delayed 2m USD

ResMed Revenue (TTM):

2.784B for Dec. 31, 2019
View 4,000+ financial data types
Browse...
View Full Chart

Revenue (TTM) Chart

Export Data
Save Image
Print Image

Historical Revenue (TTM) Data

View and export this data going back to 1992. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Dec. 31, 2019 2.784B
Sept. 30, 2019 2.699B
June 30, 2019 2.607B
March 31, 2019 2.525B
Dec. 31, 2018 2.455B
Sept. 30, 2018 2.405B
June 30, 2018 2.340B
March 31, 2018 2.273B
Dec. 31, 2017 2.196B
Sept. 30, 2017 2.125B
June 30, 2017 2.067B
March 31, 2017 2.029B
Dec. 31, 2016 1.968B
Sept. 30, 2016 1.893B
June 30, 2016 1.839B
March 31, 2016 1.773B
Dec. 31, 2015 1.742B
Sept. 30, 2015 1.710B
June 30, 2015 1.679B
March 31, 2015 1.641B
Dec. 31, 2014 1.616B
Sept. 30, 2014 1.578B
June 30, 2014 1.555B
March 31, 2014 1.554B
Dec. 31, 2013 1.540B
   
Sept. 30, 2013 1.532B
June 30, 2013 1.514B
March 31, 2013 1.472B
Dec. 31, 2012 1.437B
Sept. 30, 2012 1.393B
June 30, 2012 1.369B
March 31, 2012 1.338B
Dec. 31, 2011 1.303B
Sept. 30, 2011 1.276B
June 30, 2011 1.243B
March 31, 2011 1.193B
Dec. 31, 2010 1.158B
Sept. 30, 2010 1.127B
June 30, 2010 1.092B
March 31, 2010 1.053B
Dec. 31, 2009 1.002B
Sept. 30, 2009 949.80M
June 30, 2009 920.74M
March 31, 2009 903.93M
Dec. 31, 2008 887.89M
Sept. 30, 2008 867.59M
June 30, 2008 835.40M
March 31, 2008 791.56M
Dec. 31, 2007 762.72M
Sept. 30, 2007 738.47M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Revenues

Income that a company gains from business activities, calculated before any expenses are subtracted. Includes all sales and other increases in owner's equity. Increasing revenues over time are generally a good sign of company's growth.

While a bit obvious, if a lemonade company has sold 30 million in revenue and has 10 million in costs of goods sold, the company's revenue is still 30 million. (Expenses are not accounted in Revenue).
Learn More

Advertisement

Revenue (TTM) Benchmarks

Benchmarks
Haemonetics Corp 999.28M
NuVasive Inc 1.168B
Stryker Corp 14.88B

Revenue (TTM) Range, Past 5 Years

Minimum 1.641B Mar 2015
Maximum 2.784B Dec 2019
Average 2.137B
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.